Bank of America’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $134M | Buy |
|
|||||
2025
Q1 | $99.9M | Buy |
|
|||||
2024
Q4 | $63.6M | Sell |
|
|||||
2024
Q3 | $128M | Buy |
|
|||||
2024
Q2 | $113M | Buy |
|
|||||
2024
Q1 | $95.7M | Buy |
|
|||||
2023
Q4 | $110M | Buy |
|
|||||
2023
Q3 | $91M | Buy |
|
|||||
2023
Q2 | $92.9M | Sell |
|
|||||
2023
Q1 | $135M | Sell |
|
|||||
2022
Q4 | $137M | Sell |
|
|||||
2022
Q3 | $152M | Sell |
|
|||||
2022
Q2 | $144M | Buy |
|
|||||
2022
Q1 | $145M | Sell |
|
|||||
2021
Q4 | $219M | Buy |
|
|||||
2021
Q3 | $210M | Buy |
|
|||||
2021
Q2 | $240M | Sell |
|
|||||
2021
Q1 | $229M | Buy |
|
|||||
2020
Q4 | $166M | Sell |
|
|||||
2020
Q3 | $260M | Sell |
|
|||||
2020
Q2 | $248M | Sell |
|
|||||
2020
Q1 | $346M | Buy |
|
|||||
2019
Q4 | $302M | Sell |
|
|||||
2019
Q3 | $312M | Sell |
|
|||||
2019
Q2 | $332M | Sell |
|
|||||
2019
Q1 | $459M | Buy |
|
|||||
2018
Q4 | $580M | Sell |
|
|||||
2018
Q3 | $714M | Buy |
|
|||||
2018
Q2 | $574M | Buy |
|
|||||
2018
Q1 | $505M | Sell |
|
|||||
2017
Q4 | $618M | Sell |
|
|||||
2017
Q3 | $759M | Buy |
|
|||||
2017
Q2 | $544M | Sell |
|
|||||
2017
Q1 | $594M | Buy |
|
|||||
2016
Q4 | $561M | Buy |
|
|||||
2016
Q3 | $576M | Buy |
|
|||||
2016
Q2 | $432M | Sell |
|
|||||
2016
Q1 | $501M | Buy |
|
|||||
2015
Q4 | $486M | Buy |
|
|||||
2015
Q3 | $415M | Buy |
|
|||||
2015
Q2 | $233M | Sell |
|
|||||
2015
Q1 | $285M | Buy |
|
|||||
2014
Q4 | $217M | Sell |
|
|||||
2014
Q3 | $254M | Sell |
|
|||||
2014
Q2 | $252M | Sell |
|
|||||
2014
Q1 | $303M | Sell |
|
|||||
2013
Q4 | $309M | Buy |
|
|||||
2013
Q3 | $189M | Buy |
|
|||||
2013
Q2 | $124M | Buy |
|